In The Press
University of Hawaii Business Plan Competition 2014 - Pacific Business News, April 27, 2014
CyThera Pharmaceuticals wins second place, along with $5,000 in cash and $11,000 in accounting, legal and marketing services. CyThera is a Honolulu biotech company that repositions drugs approved by the U.S. Food and Drug Administration for new disease indications in cancer, stroke and autoimmune disorders.
CyThera Pharmaceuticals wins second place, along with $5,000 in cash and $11,000 in accounting, legal and marketing services. CyThera is a Honolulu biotech company that repositions drugs approved by the U.S. Food and Drug Administration for new disease indications in cancer, stroke and autoimmune disorders.
Isle doctors find new use for 1890s drug - Honolulu Star-Bulletin, February 23, 2009
An old anti-leprosy drug might provide an effective treatment for three devastating autoimmune diseases—multiple sclerosis, psoriasis and type 1 diabetes—say two Hawaii researchers and mainland colleagues. Read the full article at the Star-Bulletin.
An old anti-leprosy drug might provide an effective treatment for three devastating autoimmune diseases—multiple sclerosis, psoriasis and type 1 diabetes—say two Hawaii researchers and mainland colleagues. Read the full article at the Star-Bulletin.
Teaching an old drug new tricks - Johns Hopkins Medicine Press Release, January 30, 2009
Leprosy medicine holds promise as therapy for autoimmune diseases. Read the full press release at Johns Hopkins Medicine.
Leprosy medicine holds promise as therapy for autoimmune diseases. Read the full press release at Johns Hopkins Medicine.
Peer Reviewed Publications
Ren YR, Pan F, Parvez S, Fleig A, Chong CR, Xu J, Dang Y, Zhang J, Jiang H, Penner R, Liu JO (2008) Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes. PLoS One 3(12):e4009; PMCID: PMC2602975. PMED ID: 19104661.
Faouzi M, Starkus J, Penner R (2015) State-dependent blocking mechanism of Kv1.3 channels by the antimycobacterial drug clofazimine. Br. J. Pharmacol. doi: 10.1111/bph.13283. PMID: 26276903
Issued Patent
Liu JO, Ren Y, Pan F, Chong CR, Penner R, Behr, JR (2014) Phenazine derivatives and uses thereof as potassium channel modulators. United States Patent: 8669257.
